Anzeige
Mehr »
Login
Donnerstag, 26.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Während die Wall Street über Krypto-ETFs debattiert, liefert dieses Unternehmen 1.000?% RENDITE!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
511 Leser
Artikel bewerten:
(2)

CIVCO Radiotherapy & Qfix: CIVCO Radiotherapy and Qfix Showcase as One Company at ESTRO 2023

Finanznachrichten News

CORALVILLE, Iowa, May 8, 2023 /PRNewswire/ -- CIVCO Radiotherapy and Qfix, now together as one company, will exhibit their innovative and patented solutions during the annual ESTRO Congress in Vienna, Austria, 12-16 May 2023. The company encourages attendees to visit booth #200 to experience many of these solutions firsthand. Live product demonstrations will include the Encompass SRS Immobilization System, the proprietary Integrated Shim and Fibreplast® thermoplastic solutions, and the Symphony® Patient Transfer System.

The company will also have on-display many market-leading solutions and recent innovations focused on improving patient comfort and outcomes, including:

SBRT and All in One Immobilization Systems
The Body Pro-Lok ONE system features the only bridge on the market designed with variable height adjustment and lateral and tilting offset for varying body types. SBRT bridges, belts, and additional customization options are also available with the Alta Multipurpose Device (including Patient Transfer) and the TotalRT All in One Solution.

SRS Immobilization Systems
The Encompass and Solstice SRS Immobilization Systems are highly advanced, non-invasive solutions designed for precisely targeted brain, head, and neck treatments. The Encompass is validated for HyperArc and provides setup confidence and comfort with the Integrated Shim system. Solstice features unique variable pitch capability, increasing setup and treatment flexibility.

Comfort Marker 2.0 Patient Marking System
Dr. André Miranda Pires, Institute Português de Oncologia do Porto, will be available during the congress to present clinical research using the Comfort Marker 2.0, showing that patient markings produced with this system are more consistent, well-defined, and sharper than traditional lancet tattoos.

Supine and Prone Breastboards
The C-Qual M, Access, and Evolve Supine Breastboards offer many configurations and compatibilities for accurate, reproducible, and comfortable patient positioning and immobilization to treat the thorax, abdomen, and breast range. The New Horizon Prone Breastboard is modular, with many options for prone breast setups.

Proton Solutions, including Pediatric Options
Universal Couchtop and the innovative ProForm and Pediatric ProForm, provide an easy-to-use mask attachment and a homogeneous treatment region optimized for CNS patients. The kVue Couchtop with BoS® system has become a proton industry standard for head & neck immobilization with its conformal shape which allows optimal treatment beam angles.

About CIVCO Radiotherapy & Qfix
CIVCO Radiotherapy & Qfix is a global leader in developing high-quality, innovative, patient-centric radiotherapy solutions. The company has over 80 years of combined experience bringing advanced hardware and consumables for patient immobilization and positioning, fiducial markers, couchtops, and patient care products to the market. Visit www.CivcoRT.com and www.Qfix.com for more information.

For further information, please contact:
Shelli Locklear, Director of Marketing, at +1 319.248.6619 or Shelli.Locklear@CivcoRT.com

COPYRIGHT © 2023. This press release contains information about products that may or may not be available in particular countries. These products may not be licensed in accordance with Canadian law. Each country has specific laws and regulations governing the commercialization of medical devices and the communication of information regarding medical devices in printed and digital media. Products appearing in this press release or on our website may or may not have received approval, clearance, or marketing authorization by a governmental regulatory body in any particular country or may have received approval, clearance, or marketing authorization for different indications and restrictions in different countries, or may be for investigational use only. Qfix is a registered trademark of Qfix. Access, Alta, Encompass, Integrated Shim, RapidHeat, and kVue, are trademarks of Qfix. BoS, Fibreplast, and Symphony are registered trademarks of Qfix. CIVCO is a registered trademark of CIVCO Medical Solutions. CIVCO Radiotherapy, CIVCO RT, Body Pro-Lok ONE, C-Qual M, Evolve, New Horizon, ProForm, Solstice, TotalRT, and Universal Couchtop are trademarks of Medtec LLC. HyperArc is a trademark of Varian Medical Systems. 2023C1667 Rev. A

Cision View original content:https://www.prnewswire.co.uk/news-releases/civco-radiotherapy-and-qfix-showcase-as-one-company-at-estro-2023-301817193.html

© 2023 PR Newswire
6 Richtige für 2025
Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.